As expected, the plasma samples from the AML patients at diagnosis exhibited higher levels of Th17 related cytokines, including IL-1β, IL-6, IL-17 and IL-23, than those from healthy controls (Fig. 3). The gene discussed is IL17A; the disease is acute myeloid leukemia.